Heinrich Dreismann insider trades: Myriad Genetics (MYGN) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Heinrich reports to the SEC
Open-market buys and sales
2 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Sep 9, 2024 | MYGN | ↓ Sell | 10,000 | $27.05 | $271K | Direct | Sep 9, 2024 (0d) |
| Oct 27, 2006 | NGEN | ↓ Sell | 8,113 | $1.95 | $16K | Direct | Oct 31, 2006 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other MYGN insiders
Open-market trades in the last 12 months
About Heinrich Dreismann's insider trades
Heinrich Dreismann is a director at Myriad Genetics (MYGN). Since Oct 27, 2006, Heinrich has reported no open-market purchases and 2 sales worth $286K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (14 filings), shares returned to the company (1 filing), other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MYGN insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.